MOI, DAVIDE
 Distribuzione geografica
Continente #
EU - Europa 31.573
NA - Nord America 4.133
AS - Asia 1.478
SA - Sud America 229
AF - Africa 47
OC - Oceania 16
Totale 37.476
Nazione #
IT - Italia 31.058
US - Stati Uniti d'America 4.071
SG - Singapore 494
CN - Cina 423
BR - Brasile 180
VN - Vietnam 150
HK - Hong Kong 115
SE - Svezia 109
FR - Francia 105
BD - Bangladesh 66
DE - Germania 61
GB - Regno Unito 55
FI - Finlandia 40
IN - India 40
KR - Corea 38
CA - Canada 36
NL - Olanda 33
JP - Giappone 28
MX - Messico 20
AR - Argentina 19
AT - Austria 19
TR - Turchia 19
UA - Ucraina 18
IQ - Iraq 17
AU - Australia 16
PK - Pakistan 14
EG - Egitto 12
ZA - Sudafrica 12
EC - Ecuador 11
KZ - Kazakistan 11
RU - Federazione Russa 9
TW - Taiwan 9
UZ - Uzbekistan 9
ES - Italia 8
ID - Indonesia 8
IE - Irlanda 8
MA - Marocco 8
NO - Norvegia 7
PL - Polonia 7
SK - Slovacchia (Repubblica Slovacca) 7
BG - Bulgaria 5
CH - Svizzera 5
CO - Colombia 5
PE - Perù 5
PH - Filippine 5
AZ - Azerbaigian 4
KE - Kenya 4
LB - Libano 4
CL - Cile 3
DZ - Algeria 3
JM - Giamaica 3
JO - Giordania 3
LT - Lituania 3
NP - Nepal 3
RO - Romania 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
EE - Estonia 2
ET - Etiopia 2
IL - Israele 2
KG - Kirghizistan 2
LV - Lettonia 2
MY - Malesia 2
SA - Arabia Saudita 2
SN - Senegal 2
UY - Uruguay 2
BE - Belgio 1
BO - Bolivia 1
DK - Danimarca 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MM - Myanmar 1
MR - Mauritania 1
PA - Panama 1
PT - Portogallo 1
TH - Thailandia 1
TN - Tunisia 1
Totale 37.476
Città #
Cagliari 29.678
Uta 1.141
Singapore 307
Ashburn 275
San Jose 177
Fairfield 144
Dallas 127
Council Bluffs 92
Boardman 90
Beijing 78
Hong Kong 62
Houston 60
Nyköping 58
Woodbridge 58
Wilmington 57
Los Angeles 56
Hefei 55
Ho Chi Minh City 53
Santa Clara 48
Seattle 47
Cambridge 46
Chandler 40
Shanghai 40
Hanoi 38
Central 36
New York 35
Lauterbourg 33
Chicago 27
Helsinki 27
Dearborn 26
Seoul 26
Amsterdam 24
Buffalo 19
Frankfurt am Main 19
São Paulo 19
The Dalles 19
Ann Arbor 18
Tokyo 18
Milan 17
London 16
San Diego 16
Canberra 15
Rome 15
Hyderabad 14
Montreal 14
Vienna 14
Istanbul 13
Boston 12
Jacksonville 12
Guangzhou 11
Toronto 11
Tukwila 11
Wuhan 11
Astana 10
Orem 10
Nanjing 9
Redondo Beach 9
Denver 8
Dublin 8
Mexico City 8
Munich 8
Phoenix 8
San Francisco 8
Tashkent 8
Cairo 7
Lappeenranta 7
Nuremberg 7
Redwood City 7
Washington 7
Brunswick 6
Glasgow 6
Lahore 6
Oslo 6
Atlanta 5
Casablanca 5
Des Moines 5
Fremont 5
Guayaquil 5
Hải Dương 5
Naples 5
Paris 5
Quito 5
Shenzhen 5
Taichung 5
Turku 5
Zurich 5
Albany 4
Baghdad 4
Baku 4
Biely Kostol 4
Biên Hòa 4
Brooklyn 4
Columbus 4
Dong Ket 4
Düsseldorf 4
Giarre 4
Hebei 4
Kyiv 4
Nairobi 4
Nanchang 4
Totale 33.649
Nome #
Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated 3.094
Exploring the Antiviral Potential of Esters of Cinnamic Acids with Quercetin 3.035
Continuous-Flow Synthesis of Arylthio-Cyclopropyl Carbonyl Compounds 2.962
Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors 2.842
Benzofuran hydrazones as potential scaffold in the development of multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity 2.288
Indole derivatives as multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity of indole hydrazones 2.274
Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation 2.210
Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy 2.209
Synthesis and evaluation of antioxidant and antiproliferative activity of 2-arylbenzimidazoles 2.076
In-Vitro Evaluation of Antioxidant, Antiproliferative and Photo-Protective Activities of Benzimidazolehydrazone Derivatives 2.011
Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: Synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors 1.774
Sulfonamide/sulfamate switch with a series of piperazinylureido derivatives: Synthesis, kinetic and in silico evaluation as carbonic anhydrase isoforms I, II, IV, and IX inhibitors 1.525
null 1.383
Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors 1.334
Monopharmacology, polypharmacology and PROTAC approaches in drug discovery: investigation of enzyme inhibitors and antioxidant compounds 925
Synthesis of Sulfonamides Incorporating Piperidinyl-Hydrazidoureido and Piperidinyl-Hydrazidothioureido Moieties and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity 686
Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications 678
Synthesis and Antiproliferative Effect of Halogenated Coumarin Derivatives 671
Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors 616
Discovery of a New Class of 1-(4-Sulfamoylbenzoyl)piperidine-4-carboxamides as Human Carbonic Anhydrase Inhibitors 365
Low‐Impact Synthesis of γ‐Lactones through Photoinduced Baeyer‐Villiger Oxidation of Cyclic Ketones 360
Discovery of a Novel Trifluoromethyl Diazirine Inhibitor of SARS-CoV-2 Mpro 298
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 247
Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring 246
Dual Targeting Strategies on Histone Deacetylase 6 (HDAC6) and Heat Shock Protein 90 (Hsp90) 235
Synthesis of SARS-CoV-2 Mpro inhibitors bearing a cinnamic ester warhead with in vitro activity against human coronaviruses 235
Two-step continuous flow-driven synthesis of 1,1-cyclopropane aminoketones 149
Investigation on Human Carbonic Anhydrase IX and XII Inhibitory Activity and A549 Antiproliferative Activity of a New Class of Coumarinamides 148
Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives 136
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer 134
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer 122
Synthesis of α-fluorocinnamate derivatives as novel cathepsin S inhibitors with in vitro antiproliferative activity against pancreatic cancer cells 115
The prokineticin system and glia cells as pharmacological targets to control neuroinflammation and to relieve pain in a murine model of Fabry–Anderson disease 99
Synthesis and multitarget inhibitory effect of indole-based ethyl cinnamate derivatives against SARS-CoV-2 Mpro and cathepsins for broad-spectrum anti-coronavirus activity 97
Synthesis of Hydrazidoureidobenzensulfonamides Incorporating a Nicotinoyl Tail and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity 49
Chalcones. From Drug Discovery to Pharmaceutical Applications 19
Catalytic Enantioselective Synthesis of Conformationally Stable C(sp2)−C(sp3) Naphthocoumarin Atropisomers 16
Prokineticin 2 regulates the electrophysiological activity of gonadotropin-releasing hormone neurons via direct signalling in adult female mice 15
Coumarin– and Dipicolylamine–Terpenoid Hybrids as Selective Carbonic Anhydrases IX and XII Inhibitors: Mechanistic Insights and Selective Anti-Cancer Potential 13
Light-Driven [2 + 2] Cycloaddition Strategies for the Synthesis of Cyclobuta[b]indoles and Their Derivatives 13
Anticancer potential of chalcones 12
Totale 37.716
Categoria #
all - tutte 50.158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.158


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021179 0 0 0 0 0 0 0 0 0 0 0 179
2021/20221.798 125 113 190 53 90 174 189 126 108 124 183 323
2022/20232.493 239 263 167 182 247 312 188 179 125 151 306 134
2023/20243.430 90 128 89 153 292 433 467 196 203 223 510 646
2024/202514.604 3.496 4.784 3.315 850 594 648 458 85 89 68 95 122
2025/20263.293 258 182 312 271 321 178 379 246 239 495 268 144
Totale 37.716